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The introduction of radiological contrast media and
intravenous (i.v.) urography in clinical diagnostics in the
1930s enabled the discovery of several diseases, including
the medullary sponge kidney (MSK). MSK is a renal
malformation characterized by cystic anomalies of
precalyceal ducts, which is frequently associated with
nephrocalcinosis and renal stones. Although it was first
recognized by G Lenarduzzi in 1939, its thorough description
was the result of the ante litteram multidisciplinary
cooperation between a radiologist (Lenarduzzi), a urologist
(Cacchi), and a pathologist (Ricci), all at the Padua University
Hospital. These authors ‘established’ the paradigm for its
diagnosis that is still used today. I.v. urography is the gold
standard for the diagnosis of MSK, but as the technique is
used less and less, there is a concrete possibility of this renal
condition being forgotten in the future. Although the
pathogenesis of MSK has yet to be elucidated, its association
with different malformative conditions supports the idea
that it is a developmental disorder. Recent findings suggest
that MSK may be the consequence of a disruption of the
ureteral-bud/metanephric-blastema interface.
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MEDULLARY SPONGE KIDNEY
Medullary sponge kidney (MSK) is a renal malformation
associated with a high risk of nephrocalcinosis and renal
stones, with urinary acidification and concentration defects,
cystic anomalies of precalyceal ducts and a moderate risk of
developing urinary infections and renal failure. It generally
occurs sporadically, but familial cases have been reported.
Although relatively uncommon, the disorder is not rare in
patients suffering from recurrent calcium nephrolithiasis.
The prevalence in the general population is not exactly
known, as no systematic autopsy search has been performed
on the condition, and some of the radiographic features are
very subjective. In a large series of intravenous (i.v.)
urographies performed for any reason,1 pictures ranging
from a clearcut MSK to faint radiological signs of MSK, for
example, papillary ‘blush’, were found in 0.5–1%. Of course,
this only tells us the prevalence among people submitted to
i.v. urography (for which there must have been a reason), so
we can safely assume that these prevalences are too high.
About 3–5% of renal stone formers have MSK, although
much larger proportions (up to 20%) have also been
reported.2 Differences are probably due to the intensity of
investigation, the interpretation of papillary ‘blush’ and the
selection of the case population.
The diagnosis of MSK is radiographic, and i.v. urography
is still the cornerstone. Typical pictures reveal collections of
contrast medium in ectatic papillary ducts, giving the
appearance of a blush (in the mildest cases) or linear
striations, or of bouquets of papillae, when cystic dilation of
the collecting ducts is seen in the full-blown cases. Medullary
nephrocalcinosis is frequent, but not always present, and it is
not mandatory for diagnosis. Typical cases involve all renal
papillae bilaterally, but involvement may also be unilateral or
affect only a few papillae, the latter cases being the more
bewildering to diagnose. The disease is interesting in many
respects: (1) the impact of imaging techniques on its
diagnosis, both in the past and in the future, when they
will probably change our approach to the disorder; (2) the
elusive pathogenesis: we are still facing old and generic
hypotheses (anomalous congenital development of renal
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tubules with secondary cystic dilations; collecting duct
dilation secondary to obstruction by calcium salts; renal
manifestation of a systemic connective tissue disorder; renal
manifestation of primary hyperparathyroidism), despite its
possible association with developmental disorders suggesting
a malformative origin – but a recent proposal for a re-
classification of developmental disorders of the kidney3
astonishingly does not consider MSK at all.
DISCOVERY OF MSK
The discovery of MSK needs to be set in its historical
framework, that is, the introduction of radiological contrast
media and i.v. urography in clinical diagnostics.4 Ever since
1906, various chemical compounds had been suggested to
radiocontrast the kidney and urinary tract, but none were
satisfactory. Some (colloidal silver, colloidal silver iodide, and
thorium nitrate) triggered severe reactions and even death.5,6
Although the striking lack of toxicity of sodium iodide was
well established in the treatment of syphilis, it was only in
1918 that Cameron7 proposed using sodium iodide to depict
the urinary tract.
Beforehand, the only tool for the radiological investigation
of the urinary tract was ureteral catheterization and direct
imaging after inducing a pneumoperitoneum. Ureteral
catheterization could be very difficult and painful at times,
and it could cause severe complications. However, while
pyelography was clearly capable of delineating the renal
pelvis, it could not reveal the outline of the kidney itself.
Kidneys could be clearly outlined only by inducing a
pneumoperitoneum, but this procedure was not practised
generally and was cumbersome.
In 1923, Osborne et al.8 at the Mayo Clinic started to
investigate the feasibility of performing i.v. urography by
infusing 5–20 g of sodium iodide. Results were not good
enough, however. The contrast was effective in delineating
the bladder, but it was only partially successful in depicting
the renal pelvis and ureter. Furthermore, it was almost
invariably useless for renal imaging, enabling the size, shape,
and position of the kidney to be determined at best.
Although it had been established that radio-opacity
depended on the presence of iodine, it was impossible at
that time to synthesize a well-tolerated, organic compound
suitable for i.v. use. In the context of studies on the
development of bacteriostatic agents at Shering in Germany
in 1930, a well-tolerated radio-opaque medium, 5-iodine-
pyridone-N-acetic acid (‘Uroselectan’), was obtained by
binding an iodine to a pyridine ring. But it was only after
the introduction of a second iodine atom in the pyridine ring
(Perabrodil by Bayer in 1931, and Uroselectan B by Shering in
1932), which considerably improved its radio-opacity, that
urography could be launched in clinical practice.
Just like the more recent introduction of computed
tomography or nuclear magnetic resonance in diagnostics,
the exploration of the new diagnostic technique coincided
with a period of scientific fervor and enthusiasm. Urography
was a very powerful tool for investigating the kidney and
urinary system, arriving at diagnoses hitherto achievable only
in surgical or autoptic theaters. A few diseases were also
discovered. In the X-ray of Figure 1, a normal-appearing
calyceal system and pelvis are associated with a previously
unknown anomaly: the opaque medium reveals dilated
tubules in the pyramidal portion in the shape of blushes,
some of which contain calcium deposits.
THE 40-YEAR-OLD ABYSSINIAN WAR VETERAN AND THE
FIRST DESCRIPTION OF MSK
The first description of this ‘uncommon pyelographic finding
(dilation of the intrarenal urinary tract)’ was published by
Lenarduzzi9 in 1939 in an abstract form, in the Proceedings
of the Venetian Regional Association of Radiologists
(Figure 2). The patient was very probably the one described
a decade later as the ‘Premier case – CyRino, aˆge´ de quarante
ansy’ in the first detailed account of the condition by Cacchi
and Ricci.10 Indeed, Cacchi and Ricci themselves wrote that
this case had been diagnosed 11 years earlier.
Cy Rino was a 40-year-old Italian veteran of the
Abyssinian war, who was repatriated due to typhus
complicated by pyelonephritis. Lenarduzzi performed both
urography and retrograde pyelography using Uroselectan B.
The latter demonstrated intrarenal reflux of the contrast
medium. He concluded ‘The radiologist believes that the
opaque spots are due to stagnant urine in the dilated urinary
tract upstream from the renal pelvis.’ There is no image of
this case in the Archives of the Institute of Radiology at the
University of Padua; in their paper, Cacchi and Ricci10
showed one poor-quality image of this case with a schematic
explanatory drawing clearly representing an MSK condition
(Figure 3). According to Professor Romani (personal
Figure 1 | Representative urographic appearance of MSK. Typical
pyramidal blushes are evident, containing small radio-opaque spots.
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communication), former Professor of Radiology at the same
University and one of Lenarduzzi’s pupil, when Cacchi and
Ricci asked for a picture of that first case, he gave them one of
the available films, but not the best one, that he was unwilling
to part with.
Lenarduzzi correctly interpreted the radiological finding
of MSK. He clearly realized that the radio-opaque spots were
ectatic collecting ducts, not papillary cysts. Indeed, cysts are
closed cavities, so they should not communicate with the
urinary system, whereas in MSK the pyramids are like a
sponge after the water has been squeezed out of it – hence the
name of the condition.
Interestingly, some previous cases of MSK had already
been investigated by Padua radiologists, but they had been
incorrectly labeled (Figure 4).
GUERRINO LENARDUZZI (1902–1985)
Lenarduzzi (Figure 5) was born in Pinzano al Tagliamento
(Pordenone) and graduated in Medicine at the University of
Padua in 1927. In the 1930s, he was working as a radiologist
in a surgical division of the University Hospital in Padua.
There was no distinct radiology section in Italy then;
radiology was considered a diagnostic facility in surgical or
medical wards. Lenarduzzi had to interrupt his scientific
career after the outbreak of the Second World War, since he
was enrolled in 1941 as a medical officer (captain) in the
Army. In August 1942, he joined the Italian North Africa
corps in Darnah, Libya, and was appointed director of the
seventh radiological auto-ambulance. Following the rout of
the Italian and German armies in North Africa, after the
second battle in El Alamein (during the defense of Northern
Tunisia), he was made prisoner in May 1943 and interned in
a British camp, then in a British military hospital in Tunis,
where he worked as a radiologist. After the end of the war
and his return home (March 1946), he became chief of the
radiological department. In 1954, he was appointed professor
of radiology at the University of Padua Medical School,
Figure 2 | Summary from the communication presented by G
Lenarduzzi in 1939.9 Uncommon pyelographic finding (dilation of
the intrarenal urinary tract). In a patient with clinical and laboratory
signs of bilateral pyelitis, i.v. urography disclosed many small radio-
opaque spots with a distribution resembling Morgagni’s pyramids.
Renal pelvis and ureters looked normal. Normal renal pelvis and
ureters were confirmed by ascending pyelography, but the passage
(of the contrast) was observed in a few papillary ducts. The
radiologist believes that the opaque spots are due to stagnant urine
in the dilated urinary tract upstream of the renal pelvis.
Figure 3 | Urographic film and schematic drawing from the first
case of MSK described by Lenarduzzi. The picture was published
by Cacchi and Ricci10 in their first exhaustive report.
Figure 4 | Retrograde bilateral pyelogram performed in 1934
showing a mislabeled MSK case. This retrograde bilateral
pyelogram of 27 December 1934 shows dilation of the upper urinary
tract and ureters with bilateral urinary stones (coral calculus).
Numerous small calculi are evident in front of enlarged calyces. At the
time, the diagnosis was renal tuberculosis, but there was no evidence
of ureteral stenosis. Although retrograde pyelography may produce
non-specific findings in MSK (due to intrarenal backflow), and is no
longer performed to diagnosing this condition, present-day review of
this case suggests a diagnosis MSK, which was unknown in 1934
(from the ‘Archaeoradiology’ collection of the Chair of Radiology,
Department of Medical and Diagnostic Sciences, University of Padua).
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where he founded a school and his many disciples were
infected by his interest in imaging the kidney and urinary
tract, and in neuro-radiology. He retired in 1972.
ROBERTO CACCHI AND VINCENZO RICCI
Cacchi was a fellow under Professor Ravasini, founder of the
Institute of Urology in Padua, when Lenarduzzi was
operating and describing MSK at the same School of
Medicine. They certainly shared some MSK patients. It was
for a suspect urographic image and severe functional defect
of the right kidney (investigated by administering i.v. indigo-
carmine and then cystoscopically determining its appearance
in the urine coming from the two ureters) that the fifth MSK
patient described by Cacchi and Ricci,10 a 30-year-old lady,
was right nephrectomized by Cacchi. Ricci was an assistant in
the pathology department directed by Professor Bompiani in
Padua and performed the histopathological examination on
the kidney, confirming Lenarduzzi’s intuition, that is, the
existence not of true cysts, but of tubular, precalyceal ectasias.
At the end of the 1950s, Cacchi was appointed professor of
urology at the University of Ferrara, while Ricci became
professor of otorhinolaryngology at the University of Verona
in the 1970s.
FIRST DESCRIPTIONS OF MSK OUTSIDE ITALY
Since the first detailed account of the condition was written
in French,10 it is hardly surprising that the first person to
describe MSK outside Italy was Neveu, in France, in 1950,11
who was followed by many other French colleagues. A report
was published in Portuguese in 195312 and in Spanish in
1955.13 It was only in 1959 that the first article in English was
published by Lindvall, a radiologist working at the Karolinska
Institute in Stockholm.14 Lindvall correctly recognized that
Lenarduzzi had been the first to describe this condition,
coining the term ‘medullary sponge kidney’ in 1938, and this
was only possible because Cacchi and Ricci10 had given a
correct account of Lenarduzzi’s abstract. The British
literature received a first contribution a few months later.15
Although Vermooten had described congenital cystic dilation
of the renal collecting ducts as a new disease entity in 1951,16
the first American report clearly referring to MSK was
published in 1960 by Abeshouse and Abeshouse.17 Many
reports appeared in the American literature early on,
including those by Palubinskas1, who suggested that a
continuum exists between benign dilation of the collecting
ducts and the cyst-like changes resulting in symptomatic
MSK. The first paper in German was published in 1961,18
and in Japanese in 1962.19
Thus, more than 20 years elapsed between Lenarduzzi’s
discovery, presented in a 90-word abstract at an obscure local
meeting, and the worldwide recognition of MSK – made
possible by the work published in French by Cacchi and
Ricci,10 which enabled the information to circulate further in
the French-speaking world, and Lindvall’s contribution in
English in a well-renowned journal.14 In those times, it was
highly unusual for Italian investigators (in the medical
research field at least) to publish their papers in English-
language, peer-reviewed journals. If they did not use Italian,
they were more likely to write in French or German, where
they used to go for internships. In fact, judging from the
PubMed database, only two of Lenarduzzi’s 17 papers were
published in foreign journals (one in German and one in
French) and, to our knowledge, Cacchi only wrote the paper
describing MSK in the Journal d’Urologie.10 This certainly
hindered the international diffusion of original contributions
from Italian medical researchers. It was only after the first
generations of Italian medical professionals or investigators,
who went to the US or the UK to specialize or do research in
the late 1960s and early 1970s, had returned to Italy that the
Italians started writing their scientific medical articles
routinely in English. Indeed, some of the most famous
Italian nephrologists published in English for the first time in
their scientific careers only in 1969 (Professor Giuseppe
Maschio), 1970 (Professor Claudio Ponticelli) and 1972
(Professor Giuseppe D’Amico).
THE MANY NAMES OF MSK
Sponge kidney (Rene a spugna) was the term coined by
Lenarduzzi to describe this condition. Since then, many
different names have been used, that is, precalyceal
canalicular ectasia, cystic dilation of renal collecting ducts,
sponge pyramid kidney and MSK.20 They are all correct.
Conversely, although Cacchi and Ricci10 correctly described
the pathology in their paper in the Journal d’Urologie as
ectasic precalyceal tubules, their designation of the condition
as a ‘maladie kystique multiple des pyramids re´nales’ (multiple
cystic disease of the renal pyramids) is wrong. The two most
frequently used names are sponge kidney and MSK, although
the eponyms are also occasionally employed. In the early
literature, Cacchi and Ricci were mentioned more frequently
in the French literature, while the Scandinavian and
Figure 5 | Guerrino Lenarduzzi in 1946. Picture taken during a
Meeting of the Venetian Radiologists held in Venice on 19 May 1946.
Lenarduzzi is in the front row, holding a hat and briefcase.
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Anglo-American literature generally referred to Lenarduzzi.
Since 1952, however, in the over 500 papers dealing with
MSK found in PubMed (using the words Cacchi and Ricci or
sponge kidney or spongy kidney), ‘Cacchi and Ricci’ occurs
27 times and ‘Lenarduzzi’ only once.21
As early as 1960, Professor Ravasini recognized the role of
both Lenarduzzi and Cacchi and Ricci in describing this renal
disease, and suggested using all three names in the eponym.
Indeed, in his preface to Cacchi’s essay ‘Il Rene a Spugna’,22
he wrote, ‘The sponge kidney is the outcome of the bright,
but independent investigations of a radiologist, and of a
urologist in cooperation with a pathologist, and this
condition should properly be indicated in the literature as
the ‘Lenarduzzi, Cacchi and Ricci’ disease’. We agree with him
entirely and suggest that the eponym for MSK be ‘Lenar-
duzzi, Cacchi and Ricci disease’ (Lena:dutsi–Cakki–Ri:t
R
i).
CLINICAL ASPECTS
Although MSK may be silent, its anatomical characteristics
and association with functional alterations mean that it is
frequently complicated by nephrolithiasis and pyelonephritis.
Other, less frequent manifestations are gross and microscopic
hematuria, renal failure and primary hyperparathyroidism.
Recurrent calcium nephrolithiasis and nephrocalcinosis
are the most common signs. The association with renal
hypercalciuria, distal tubular acidosis, and hypocitraturia (in
conjunction with urinary stasis in the papillary duct ectasias)
triggers the formation of calcium phosphate and/or calcium
oxalate stones.
Hyperparathyroidism is frequently associated, and was
thought to cause MSK and also trigger stone formation in
these patients.23 However, in most patients, hypercalciuria,
nephrocalcinosis, and renal stones clearly precede the onset
of hyperparathyroidism by many years. It was also suggested
that renal hypercalciuria triggers the parathyroid gland
stimulation leading to hyperplasia.24 Nevertheless, we now
believe that both hyperparathyroidism and stones might be
secondary to common disorders.
In addition to the morphological abnormalities of the
precalyceal ducts, MSK is associated with other abnormalities
of the lower tubule, such as a defective urinary concentration,
distal renal tubular acidosis and hypocitraturia, and also of
the upper nephron (in the proximal tubule), that is,
maximum reabsorption of glucose (TmGlucose) and max-
imum secretion of P-aminohippurate (TmPAH).25
The risk of renal failure seems to be modest in MSK and
related to renal infections and the formation of struvite
stones.26,27
Familial cases have been reported,28–31 sometimes asso-
ciated with renal agenesia, other renal malformations or
abnormalities in the urinary tract.32 An autosomal dominant
pattern of inheritance has been suggested in familial cases.30–32
WILL MSK NO LONGER BE DIAGNOSED?
The growing tendency to reduce the diagnostic use of
urography since the introduction of imaging techniques that
do not depend on radio-opaque contrasts (ultrasound, spiral
computed tomography, nuclear magnetic resonance) will
probably mean that fewer cases of MSK are diagnosed.
Although it has been suggested that kidney ultrasound can
diagnose MSK,33 it does not produce the typical images
disclosed at urography, which are considered specific of the
disorder. Ultrasound merely shows very nonspecific signs of
hyperechoic medulla due to nephrocalcinosis.34 The sensi-
tivity of computed tomography in detecting MSK is markedly
lower than that of urography, as computed tomography can
only show images pointing to the possibility of MSK even in
the most florid cases of the disease.35 Recent preliminary data
have suggested that multiphasic helical computed tomo-
graphy may be more sensitive than urography; however,36
nuclear magnetic resonance imaging does not seem to be
sensitive enough to disclose the typical signs of MSK.37 Thus,
MSK emerged with the introduction of urography in clinics
and, like a carsic river, seems destined to disappear again (i.e.
to be diagnosed less and less).
Although the condition and its complications have no
specific treatment, its recognition in recurrent stone formers
is certainly useful in tailoring stone prophylaxis and for a
proper approach to the diagnosis and treatment of the
frequently associated hyperparathyroidism. Hence, our con-
viction that urography should still be considered as a
necessary step in the diagnostic workup for recurrent calcium
stone formers.
A MODERN LOOK AT MSK: ON THE TRACK OF ITS
MOLECULAR BASES
Although the pathogenesis of MSK has yet to be elucidated,
its association with different malformative conditions
(Table 1) supports the idea that it is a developmental
disorder. The most important of these associated conditions
are hemihypertrophy and the Beckwith-Wiedemann syn-
drome.38 When MSK is associated with Wilms’ tumor, this
generally occurs in the context of a hemihypertrophy/
Beckwith-Wiedemann syndrome. About one in eight patients
with Beckwith-Wiedemann syndrome has some degree of
hemihypertrophy, rising to 40% in those with associated
tumors. In a pediatric case population with Beckwith-
Wiedemann syndrome, hypercalciuria was found in 22%
(as opposed to a predicted rate of 7–10% in the general
population) and most patients had nephrocalcinosis (sug-
gesting that they also had MSK).39 Chesney et al.40 have even
suggested that MSK and hemihypertrophy represent a subtle
form of Beckwith-Wiedemann syndrome. So there is a sort of
triangulation between MSK, Wilm’s tumor, and hemihyper-
trophy/Beckwith-Wiedemann syndrome. The latter are
known to be associated with a locus on chromosome
11p15,41 whereas Wilm’s tumor is associated with alterations
in the WT-1 gene at 11p13. Thus the two loci are very close,
supporting the view that the overlap between the three
disorders could depend on a derangement occurring in the
11p chromosome area, along the lines of the so-called
‘contiguous gene syndromes’.
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A second group of conditions associated with MSK
includes congenital dilation of intrahepatic bile ducts and
hepatic fibrosis,42 and autosomal dominant polycystic kidney
disease (ADPKD). Regarding the association with liver
conditions, it is worth noting that the excretory ducts in
both organs derive from the endoderm, and liver fibrosis has
been reported in association with ADPKD too.43 Several case
reports have been published in which MSK occurred together
with cortical cysts in polycystic kidney disease, but more
interestingly 15% of a population of 71 ADPKD cases with
renal stones reportedly had evidence of precalyceal tubular
ectasia, supporting the idea that ADPKD and MSK may truly
coexist.44
The other associated conditions listed in Table 1 are
uncommon or anecdotal. Although some of these may be
chance associations, it is intriguing that some form
syndromes of local tissue hypertrophy,2 which reinforce the
potential triangulation with MSK and more generalized
hypertrophic disorders.
The pathogenesis of MSK should explain the involvement
of anatomical districts (the collecting and precalyceal ducts
on the one hand and the nephron on the other) of different
embryological origins. It should also explain why it is so often
associated with primary hyperparathyroidism.
A few years ago, a case was described of a medullary
thyroid carcinoma presenting with concomitant primary
hyperparathyroidism (prompting the diagnosis of MEN-2a)
together with MSK, and a RET (rearranged during transfec-
tion) proto-oncogene gene mutation, and it was claimed that
the MSK/RET mutation association may be causal.45 How-
ever, we expect to find a RET mutation in a patient with a
medullary thyroid carcinoma, since this occurs in 80% of
cases. Moreover, given the prevalence of the two conditions
(as high as 10/100 000 for the former, up to 1/100 for MSK),
the probability of a chance association (up to 1 per million
people), though very low, is nonetheless a possibility. The
idea of common pathogenic mechanisms in the two diseases
is attractive, however, since RET plays a huge part in renal
development.
In renal embryogenesis, through the synthesis of chemo-
tactic molecules, that is, the glial-derived neurotrophic factor
(GDNF), the metanephric blastema prompts the branching
of the ureteral-bud from Wolff ’s mesonephric duct, which
approaches and invades the blastema.46 The top of the bud
expresses a GDNF receptor, RET. Binding between RET and
GDNF is essential not only for correct ureter and collecting
duct formation (they also are Wolffian in origin), but also for
the induction of nephrogenesis, morphogenesis, and kidney
growth.46 In particular, the transition of mesenchymal cells of
the metanephros to nephronic cells, the correct polarization
of renal tubular cells, and the specialization of the different
tubular segments of the nephron, all need differentiation
‘messages’ originating from the ureteral-bud/metanephric-
blastema interface.46
We have hypothesized that MSK may be the consequence
of a disruption of said interface:47 this would explain the
concomitant occurrence of alterations in precalyceal and
collecting ducts, and functional defects in the nephron
tubule. Moreover, if the disruption of the ureteral-bud/
metanephric-blastema interface depends on some derange-
ment in RET function, then the hypothesis would also
explain the abnormal parathyroid function, in view of this
oncogene’s role in controlling parathyroid cell proliferation,48
and the association of MSK with liver disorders due to its
possible role in the development of the liver excretory
system.49 But other candidate genes may be suggested for this
abnormal embryological development,46 such as the glial-
derived factor neurturin, which is also capable of promoting
ureteric-bud branching; or the WT1 gene which is involved
in ureteral-bud induction; and many others, including Eyes
absent 1 (Eya-1), integrins, PAX2, laminin a5, AgtR2, FGFs,
MT1-MMP, MMP9, TIMP1, TIMP2, all involved in the
process of nephrogenesis. However, as most of them continue
to be active after embryogenesis, they are less likely to be
involved because patients with MSK do not reveal disorders
due to mutations of these genes. On the other hand, the WT1
gene is much more intriguing as a possible candidate because
of the association of MSK with Wilms’ tumor and
hypertrophic disorders.
Abnormal interfacing of the ureteral bud with the
blastema may be secondary to environmental influences
(drugs, viruses, etc.) during pregnancy. It may also be
genetically driven, however, despite the rarity of cases of
Table 1 | Disorder associated with MSK
Prevalence (%)
Reports in
PubMed
Text
books
Beckwith-Wiedemann syndrome 13% (Choyke
et al.38)a
Congenital hemihypertrophy 15
Wilm’s tumor 5b
Horse-shoe kidney 2
Polycystic renal diseasec 5
Other urinary tract malformations 10% (Gambaro
et al.47)d
Caroli syndrome and congenital
Hepatic fibrosis
B70% (Kerr
et al.42)e
Anodontia 1
Ehlers-Danlos syndrome 1
Marfan syndrome 1
Young’s syndrome (immotile cilia) 2
Congenital pyloric stenosis 1
Renal artery fibromuscular dysplasia Yes
The association between MSK and the listed disorders is indicated as prevalence
whenever the datum is available, or as number of case reports if the former is not
available, or as textbook (Oxford Textbook of Nephrology) citation when no case
report is retraceable in the PubMed database.
aPrevalence of MSK in a cohort of patients with Beckwith-Wiedemann syndrome.
bAlways in association with the Beckwith-Wiedemann syndrome or congenital
hemihypertrophy.
cIt is not clear whether inheritance of the polycystic condition was recognized in all
case reports, thus making the ADPKD diagnosis uncertain. On the other hand, 15%
out of a case population of 71 ADPKD with renal stones has been reported to have
evidence of precalyceal tubular ectasia supporting that ADPKD and MSK may truly
coexist.44
dPrevalence of malformations in a cohort of MSK patients.
ePrevalence of MSK in a cohort of patients with congenital hepatic fibrosis.
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familial MSK. Even germline mutations might cause sporadic
forms of MSK via a number of mechanisms: (1) incomplete
penetrance; (2) if a two-hit phenomenon is needed for the
onset of MSK (as in ADPKD or other developmental kidney
disorders, such as von Hippel–Lindau syndrome or tuberous
sclerosis); (3) if MSK is due to unfavorable genotype
combinations, for example, between specific RET and GDNF
alleles; (4) if a concomitant mutation of the GDNF ligand
gene is needed; and finally (5) if MSK is not a simple
Mendelian trait, but follows a polygenic pattern of inheri-
tance affected by modifier genes, as in another RET-
associated disorder – Hirschprung’s disease – which also
occurs quite often in sporadic forms, like MSK.50
Along with this wide range of possibilities, it may also be
that the differentiative abnormality occurs throughout both
kidneys, only in one kidney, or even in just a few papillae.
Molecular studies are needed to confirm the hypothesis
but, if it proves correct, we would expect to find other renal
developmental abnormalities of processes depending on
RET/GDNF binding (i.e. unilateral renal agenesia, or
unilateral or bilateral renal hypoplasia, or renal district
duplication, etc.) much more frequently in MSK patients
than the few anecdotal cases of horse-shoe kidney, unilateral
renal aplasia,51 and familial cosegregation of various ureteral
abnormalities.32 We ourselves have observed six cases of
congenital, monolateral small kidneys in a systematic analysis
of 72 MSK patients.47
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